Home > Financial Ratios > BAL PHARMA

BAL PHARMA
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) 43.52-15.0823.562,138.47-106.36

What is the latest EBIT Growth ratio of BAL PHARMA ?

The latest EBIT Growth ratio of BAL PHARMA is 43.52 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar202443.52
Mar2023-15.08
Mar202223.56
Mar20212,138.47
Mar2020-106.36

How is EBIT Growth of BAL PHARMA Trending?

Years EBIT Growth % Change
Mar2024 43.52
Positive
Mar2023 -15.08
Negative
Mar2022 23.56
-98.90
Mar2021 2138.47
Positive
Mar2020 -106.36 -

Other Financial Ratios of BAL PHARMA


Compare EBIT Growth ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹181.7 Cr 3.9% -9.6% -13.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,228.0 Cr -2.4% -7.2% 27.2% Stock Analytics
DIVIS LABORATORIES ₹148,023.0 Cr 0% -9.2% 61.5% Stock Analytics
CIPLA ₹119,474.0 Cr 6% -3.8% 10.7% Stock Analytics
DR REDDYS LABORATORIES ₹101,599.0 Cr 1.7% -11.4% 2.2% Stock Analytics
ZYDUS LIFESCIENCES ₹97,604.7 Cr 5.2% -2.1% 26.1% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

3.9%

-9.6%

-13.3%

SENSEX

1.7%

-1.3%

7.7%


You may also like the below Video Courses